ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
ARTV
48 hedge funds and large institutions have $319M invested in Artiva Biotherapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$152M |
2 |
5VM
5AM Venture Management
San Francisco,
California
|
+$36.4M |
3 |
VA
VR Adviser
New York
|
+$24.9M |
4 |
VP
venBio Partners
San Francisco,
California
|
+$23.5M |
5 |
Capital World Investors
Los Angeles,
California
|
+$14.1M |
Top Sellers
No sellers this quarter